{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:49:04Z","timestamp":1791748144026,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["GR2019-12369202"],"award-info":[{"award-number":["GR2019-12369202"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.suronc.2026.102456","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T06:58:47Z","timestamp":1779865127000},"page":"102456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Metabolomic profiling of pancreatic juice: a potential prognostic tool for pancreatic ductal adenocarcinoma"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8475-9885","authenticated-orcid":false,"given":"E.","family":"Desiato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Barbagallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Brunelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Nappo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Gavazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ridolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pagnanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Luberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Zerbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Marchesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Capretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.suronc.2026.102456_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"21","key":"10.1016\/j.suronc.2026.102456_bib2","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1200\/JCO.2016.67.5553","article-title":"Potentially curable pancreatic cancer: american society of clinical oncology clinical practice guideline","volume":"34","author":"Khorana","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.suronc.2026.102456_bib3","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1245\/s10434-008-0295-2","article-title":"Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma","volume":"16","author":"Katz","year":"2009","journal-title":"Ann. Surg Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2026.102456_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/bjs\/znac354","article-title":"Surgical resection rates after neoadjuvant therapy for localized pancreatic ductal adenocarcinoma: meta-analysis","volume":"110","author":"Brown","year":"2022","journal-title":"Br. J. Surg."},{"issue":"3","key":"10.1016\/j.suronc.2026.102456_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/AS9.0000000000000087","article-title":"Resectability of pancreatic cancer is in the eye of the observer","volume":"2","author":"Giannone","year":"2021","journal-title":"Ann. Surg. Open"},{"issue":"14","key":"10.1016\/j.suronc.2026.102456_bib6","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1158\/0008-5472.CAN-23-2213","article-title":"Metabolic reprogramming is an initial step in pancreatic carcinogenesis that can be targeted to inhibit acinar-to-ductal metaplasia","volume":"84","author":"Neu\u00df","year":"2024","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.suronc.2026.102456_bib7","first-page":"7487","article-title":"HCMMD: systematic evaluation of metabolites in body fluids as liquid biopsy biomarker for human cancers","volume":"16","author":"Dong","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.suronc.2026.102456_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-1-4939-9027-6_12","article-title":"Mass spectrometry-based profiling of metabolites in human biofluids","volume":"1928","author":"Chakraborty","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.suronc.2026.102456_bib9","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1038\/s41467-023-37875-1","article-title":"Metabolomic differentiation of benign vs malignant pulmonary nodules with high specificity via high-resolution mass spectrometry analysis of patient sera","volume":"14","author":"Yao","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.suronc.2026.102456_bib10","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1136\/gutjnl-2021-325189","article-title":"Integrative metabolomic characterisation identifies altered portal vein serum metabolome contributing to human hepatocellular carcinoma","volume":"71","author":"Liu","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.suronc.2026.102456_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/srep31520","article-title":"Identification of salivary metabolomic biomarkers for oral cancer screening","volume":"6","author":"Ishikawa","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.suronc.2026.102456_bib12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.urolonc.2011.05.013","article-title":"Urine metabolomics for kidney cancer detection and biomarker discovery","volume":"29","author":"Ganti","year":"2011","journal-title":"Urol. Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2026.102456_bib13","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.3892\/mmr.2014.2973","article-title":"Identification of bile biomarkers of biliary tract cancer through a liquid chromatography\/mass spectrometry-based metabolomic method","volume":"11","author":"Xu","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.suronc.2026.102456_bib14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1158\/2326-6066.CIR-19-0403","article-title":"Metabolome of pancreatic juice delineates distinct clinical profiles of pancreatic cancer and reveals a link between glucose metabolism and PD-1+ cells","volume":"8","author":"Cortese","year":"2020","journal-title":"Cancer Immunol. Res."},{"issue":"2","key":"10.1016\/j.suronc.2026.102456_bib15","first-page":"93","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.suronc.2026.102456_bib16","article-title":"Isolation of proximal fluids to investigate the tumor microenvironment of pancreatic adenocarcinoma","volume":"165","author":"Donisi","year":"2020","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.suronc.2026.102456_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1405612","article-title":"Integrating metabolic profiling of pancreatic juice with transcriptomic analysis of pancreatic cancer tissue identifies distinct clinical subgroups","volume":"14","author":"Pulvirenti","year":"2024","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2026.102456_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13010013","article-title":"EASY-FIA: a readably useable standalone tool for high-resolution mass spectrometry metabolomics data pre-processing","volume":"13","author":"Morabito","year":"2022","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.suronc.2026.102456_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann. Surg."},{"issue":"1","key":"10.1016\/j.suronc.2026.102456_bib20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/gutjnl-2016-312432","article-title":"Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis","volume":"67","author":"Mayerle","year":"2018","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.suronc.2026.102456_bib21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1158\/1055-9965.EPI-12-1033","article-title":"A novel serum metabolomics-based diagnostic approach to pancreatic cancer","volume":"22","author":"Kobayashi","year":"2013","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"1","key":"10.1016\/j.suronc.2026.102456_bib22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11306-009-0178-y","article-title":"Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles","volume":"6","author":"Sugimoto","year":"2010","journal-title":"Metabolomics"},{"issue":"3","key":"10.1016\/j.suronc.2026.102456_bib23","article-title":"Diagnostic and prognostic performance of metabolic signatures in pancreatic ductal adenocarcinoma: the clinical application of quantitative nextgen mass spectrometry","volume":"14","author":"D'Amora","year":"2024","journal-title":"Metabolites"},{"issue":"19","key":"10.1016\/j.suronc.2026.102456_bib24","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1158\/1078-0432.CCR-14-2469","article-title":"New DNA methylation markers for pancreatic cancer: discovery, tissue validation, and pilot testing in pancreatic juice","volume":"21","author":"Kisiel","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.suronc.2026.102456_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10121056","article-title":"Early detection of pancreatic cancer: role of biomarkers in pancreatic fluid samples","volume":"10","author":"Ideno","year":"2020","journal-title":"Diagnostics"},{"issue":"2","key":"10.1016\/j.suronc.2026.102456_bib26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MPA.0b013e31822862f6","article-title":"The proteome of normal pancreatic juice","volume":"41","author":"Doyle","year":"2012","journal-title":"Pancreas"},{"issue":"5","key":"10.1016\/j.suronc.2026.102456_bib27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41422-022-00614-0","article-title":"Comprehensive metabolomics expands precision medicine for triple-negative breast cancer","volume":"32","author":"Xiao","year":"2022","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.suronc.2026.102456_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/nbm.797","article-title":"Visualizing metabolic changes in breast-cancer tissue using 1H-NMR spectroscopy and self-organizing maps","volume":"16","author":"Beckonert","year":"2003","journal-title":"NMR Biomed."},{"issue":"1","key":"10.1016\/j.suronc.2026.102456_bib29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11306-023-02076-w","article-title":"Metabolomic profiling of human bladder tissue extracts","volume":"20","author":"Ossoli\u0144ski","year":"2024","journal-title":"Metabolomics"},{"key":"10.1016\/j.suronc.2026.102456_bib30","article-title":"Prognostic factors in localized pancreatic ductal adenocarcinoma after neoadjuvant therapy and resection: a systematic review and meta-analysis","author":"Javed","year":"2024","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.suronc.2026.102456_bib31","first-page":"340","article-title":"The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates","volume":"13","author":"Poruk","year":"2013","journal-title":"Curr. Mol. Med."},{"issue":"8","key":"10.1016\/j.suronc.2026.102456_bib32","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.pan.2024.11.011","article-title":"Characteristics and prognosis of patients with pancreatic adenocarcinoma not expressing CA19-9: analysis of the National Cancer Database","volume":"24","author":"Sugawara","year":"2024","journal-title":"Pancreatology"},{"issue":"31","key":"10.1016\/j.suronc.2026.102456_bib33","doi-asserted-by":"crossref","first-page":"10802","DOI":"10.3748\/wjg.v20.i31.10802","article-title":"Prognostic factors related with survival in patients with pancreatic adenocarcinoma","volume":"20","author":"Bilici","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.suronc.2026.102456_bib34","doi-asserted-by":"crossref","first-page":"zraf033","DOI":"10.1093\/bjsopen\/zraf033","article-title":"Anatomically resectable versus biologically borderline resectable pancreatic cancer definition: refining the border beyond anatomical criteria and biological aggressiveness","volume":"9","author":"Belfiori","year":"2025","journal-title":"BJS Open"},{"issue":"2","key":"10.1016\/j.suronc.2026.102456_bib35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/1878-0261.13759","article-title":"Global metabolomic profiling of tumor tissue and paired serum samples to identify biomarkers for response to neoadjuvant FOLFIRINOX treatment of human pancreatic cancer","volume":"19","author":"Amrutkar","year":"2025","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2026.102456_bib36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13058-024-01813-w","article-title":"Metabolomics assisted by transcriptomics analysis to reveal metabolic characteristics and potential biomarkers associated with treatment response of neoadjuvant therapy with TCbHP regimen in HER2 + breast cancer","volume":"26","author":"Zhang","year":"2024","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.suronc.2026.102456_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/1878-0261.13344","article-title":"Neoadjuvant chemotherapy is associated with an altered metabolic profile and increased cancer stemness in patients with pancreatic ductal adenocarcinoma","volume":"17","author":"Amrutkar","year":"2023","journal-title":"Mol. Oncol."},{"issue":"4","key":"10.1016\/j.suronc.2026.102456_bib38","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1158\/2159-8290.CD-19-0297","article-title":"Oncogenic KRAS-driven metabolic reprogramming in pancreatic cancer cells utilizes cytokines from the tumor microenvironment","volume":"10","author":"Dey","year":"2020","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.suronc.2026.102456_bib39","article-title":"Cholesterol metabolism in pancreatic cancer and associated therapeutic strategies","volume":"1870","author":"Daya","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"22","key":"10.1016\/j.suronc.2026.102456_bib40","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.1158\/0008-5472.CAN-20-1255","article-title":"KRAS controls pancreatic cancer cell lipid metabolism and invasive potential through the lipase HSL","volume":"80","author":"Rozeveld","year":"2020","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.suronc.2026.102456_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.3916","article-title":"Nuclear magnetic resonance (NMR)-based metabolomics for cancer research","volume":"32","author":"Ranjan","year":"2019","journal-title":"NMR Biomed."}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740426001076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740426001076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:34:29Z","timestamp":1791747269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740426001076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":41,"alternative-id":["S0960740426001076"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2026.102456","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomic profiling of pancreatic juice: a potential prognostic tool for pancreatic ductal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2026.102456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102456"}}